TCRT logo

Alaunos Therapeutics (TCRT) Total Liabilities

Annual Total Liabilities

$1.96 M
-$24.43 M-92.59%

December 31, 2023


Summary


Performance

TCRT Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTCRTbalance sheetmetrics:

Quarterly Total Liabilities

$826.00 K
-$81.00 K-8.93%

September 30, 2024


Summary


Performance

TCRT Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTCRTbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

TCRT Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-92.6%-8.9%
3 y3 years-91.3%-98.2%
5 y5 years-79.4%-96.1%

TCRT Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-94.7%at low-97.8%at low
5 y5-year-94.7%at low-98.2%at low
alltimeall time-97.0%>+9999.0%-99.5%+8594.7%

Alaunos Therapeutics Total Liabilities History

DateAnnualQuarterly
Sep 2024
-
$826.00 K(-8.9%)
Jun 2024
-
$907.00 K(-26.9%)
Mar 2024
-
$1.24 M(-36.6%)
Dec 2023
$1.96 M(-92.6%)
$1.96 M(-64.7%)
Sep 2023
-
$5.54 M(-11.7%)
Jun 2023
-
$6.28 M(-67.2%)
Mar 2023
-
$19.13 M(-27.5%)
Dec 2022
$26.38 M(-28.3%)
$26.38 M(-25.1%)
Sep 2022
-
$35.23 M(+4.4%)
Jun 2022
-
$33.75 M(-5.9%)
Mar 2022
-
$35.87 M(-2.6%)
Dec 2021
$36.81 M(+64.6%)
$36.81 M(-18.3%)
Sep 2021
-
$45.05 M(+143.8%)
Jun 2021
-
$18.48 M(-19.0%)
Mar 2021
-
$22.83 M(+2.1%)
Dec 2020
$22.36 M(+58.6%)
$22.36 M(+6.6%)
Sep 2020
-
$20.98 M(+14.8%)
Jun 2020
-
$18.27 M(+1.8%)
Mar 2020
-
$17.94 M(+27.2%)
Dec 2019
$14.10 M(+48.7%)
$14.10 M(+19.3%)
Sep 2019
-
$11.82 M(+5.8%)
Jun 2019
-
$11.18 M(+20.4%)
Mar 2019
-
$9.29 M(-2.1%)
Dec 2018
$9.49 M(-83.8%)
$9.49 M(-84.9%)
Sep 2018
-
$62.79 M(+2.6%)
Jun 2018
-
$61.19 M(-0.6%)
Mar 2018
-
$61.57 M(+5.4%)
Dec 2017
$58.42 M(+0.2%)
$58.42 M(+2.0%)
Sep 2017
-
$57.29 M(+0.8%)
Jun 2017
-
$56.85 M(-5.2%)
Mar 2017
-
$59.95 M(+2.8%)
Dec 2016
$58.33 M(-12.1%)
$58.33 M(-2.3%)
Sep 2016
-
$59.73 M(-66.8%)
Jun 2016
-
$180.00 M(+181.8%)
Mar 2016
-
$63.87 M(-3.7%)
Dec 2015
$66.35 M(+482.2%)
$66.35 M(-16.6%)
Sep 2015
-
$79.52 M(+484.8%)
Jun 2015
-
$13.60 M(+23.1%)
Mar 2015
-
$11.04 M(-3.1%)
Dec 2014
$11.40 M(-49.1%)
$11.40 M(-9.8%)
Sep 2014
-
$12.63 M(-28.4%)
Jun 2014
-
$17.63 M(-18.3%)
Mar 2014
-
$21.59 M(-3.5%)
Dec 2013
$22.37 M(-36.0%)
$22.37 M(-13.4%)
Sep 2013
-
$25.85 M(-1.6%)
Jun 2013
-
$26.27 M(+3.2%)
Mar 2013
-
$25.45 M(-27.2%)
DateAnnualQuarterly
Dec 2012
$34.96 M(-4.2%)
$34.96 M(-25.0%)
Sep 2012
-
$46.61 M(-0.3%)
Jun 2012
-
$46.74 M(+8.3%)
Mar 2012
-
$43.17 M(+18.3%)
Dec 2011
$36.50 M(+17.9%)
$36.50 M(-4.4%)
Sep 2011
-
$38.16 M(-21.6%)
Jun 2011
-
$48.69 M(-0.4%)
Mar 2011
-
$48.91 M(+57.9%)
Dec 2010
$30.97 M(+43.2%)
$30.97 M(+22.7%)
Sep 2010
-
$25.25 M(+27.9%)
Jun 2010
-
$19.74 M(-42.7%)
Mar 2010
-
$34.45 M(+59.3%)
Dec 2009
$21.63 M(+270.8%)
$21.63 M(+417.5%)
Sep 2009
-
$4.18 M(+11.4%)
Jun 2009
-
$3.75 M(-9.3%)
Mar 2009
-
$4.14 M(-29.1%)
Dec 2008
$5.83 M(-8.2%)
$5.83 M(+1.3%)
Sep 2008
-
$5.76 M(-7.7%)
Jun 2008
-
$6.24 M(-8.1%)
Mar 2008
-
$6.79 M(+6.8%)
Dec 2007
$6.36 M(+113.4%)
$6.36 M(+24.5%)
Sep 2007
-
$5.11 M(+32.0%)
Jun 2007
-
$3.87 M(+13.8%)
Mar 2007
-
$3.40 M(+14.1%)
Dec 2006
$2.98 M(+30.1%)
$2.98 M(-10.3%)
Sep 2006
-
$3.32 M(+24.0%)
Jun 2006
-
$2.68 M(+32.2%)
Mar 2006
-
$2.02 M(-11.6%)
Dec 2005
$2.29 M(+44.1%)
$2.29 M(+31.0%)
Sep 2005
-
$1.75 M(>+9900.0%)
Jun 2005
-
$9900.00(-43.8%)
Mar 2005
-
$17.60 K(-98.9%)
Dec 2004
$1.59 M(+6084.0%)
$1.59 M(>+9900.0%)
Sep 2004
-
$14.90 K(+8.8%)
Jun 2004
-
$13.70 K(-48.3%)
Mar 2004
-
$26.50 K(+3.1%)
Dec 2003
$25.70 K(+44.4%)
$25.70 K(+32.5%)
Sep 2003
-
$19.40 K(+26.8%)
Jun 2003
-
$15.30 K(-33.5%)
Mar 2003
-
$23.00 K(+29.2%)
Dec 2002
$17.80 K(+6.0%)
$17.80 K(+52.1%)
Sep 2002
-
$11.70 K(+15.8%)
Jun 2002
-
$10.10 K(+6.3%)
Mar 2002
-
$9500.00(-43.5%)
Dec 2001
$16.80 K
$16.80 K(+35.5%)
Sep 2001
-
$12.40 K(-13.9%)
Jun 2001
-
$14.40 K

FAQ

  • What is Alaunos Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Alaunos Therapeutics?
  • What is Alaunos Therapeutics annual total liabilities year-on-year change?
  • What is Alaunos Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Alaunos Therapeutics?
  • What is Alaunos Therapeutics quarterly total liabilities year-on-year change?

What is Alaunos Therapeutics annual total liabilities?

The current annual total liabilities of TCRT is $1.96 M

What is the all time high annual total liabilities for Alaunos Therapeutics?

Alaunos Therapeutics all-time high annual total liabilities is $66.35 M

What is Alaunos Therapeutics annual total liabilities year-on-year change?

Over the past year, TCRT annual total liabilities has changed by -$24.43 M (-92.59%)

What is Alaunos Therapeutics quarterly total liabilities?

The current quarterly total liabilities of TCRT is $826.00 K

What is the all time high quarterly total liabilities for Alaunos Therapeutics?

Alaunos Therapeutics all-time high quarterly total liabilities is $180.00 M

What is Alaunos Therapeutics quarterly total liabilities year-on-year change?

Over the past year, TCRT quarterly total liabilities has changed by -$81.00 K (-8.93%)